Patrick Burnett, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 24,232 shares at $12.70 ($308K) on 2025-02-03, disclosed to the SEC on 2025-02-04.
Scheduled sale ($308k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.70 | 12,116 | $154K | 50.0% |
| 2 | $12.70 | 12,116 | $154K | 50.0% |
| Total | $12.70 avg | 24,232 | $308K | 100% |
| Filing → |
| ARQT | SELL | 2026-08-05 | $25K | — | Filing → |
| ARQT | SELL | 2026-05-13 | $5K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $16K | — | Filing → |